Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
18F-DOPA-PET/MRI Guided Proton Beam Therapy for Elderly Glioblastoma
NCT03778294Phase 2Completed
- Sponsor
- Mayo Clinic
- Start
- Mar 2019
- Primary completion
- Jun 2022
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial in glioblastoma (GBM), sponsored by Mayo Clinic. Primary endpoint: Overall Survival at 12 months. Started Mar 2019; status: completed.
02
Conditions
glioblastoma (GBM)
Beyond the preview
Go deeper on NCT03778294.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03778294.